Update. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 200

Morbidity and Mortality Weekly Report

Volumn 50, Issue 42, 2001, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038842743     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. CDC. Update: investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR 2001;50:889-97.
2. Keim P, Price LB, Klevytska AM, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships with Bacillus anthracis. J Baceriol 2000;182:2928-36.
3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Wayne, Pennsylvania: National Committee for Clinical Laboratory Standards, 2001; 11th informational supplement M100-S11.
4. Lightfoot NF, Scott RJ, Turnbull PC. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Med Bull 1990;68:95S-98S.
5. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999;341:815-26.
6. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999;281:1735-45.